Application of ADDA and/or DMTA in preparing medicine for improving expression level of gamma-globin

A technology of globin and drugs, applied in the direction of drug combinations, pharmaceutical formulas, medical preparations containing active ingredients, etc.

Inactive Publication Date: 2012-05-23
NANJING UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] There is no report on the use of ADDA or DMTA for the preparation of gamma-globin inducers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ADDA and/or DMTA in preparing medicine for improving expression level of gamma-globin
  • Application of ADDA and/or DMTA in preparing medicine for improving expression level of gamma-globin
  • Application of ADDA and/or DMTA in preparing medicine for improving expression level of gamma-globin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] 1. Materials and methods

[0022] 1) Compound

[0023] ADDA (adenosine-2', 3'-dialdehyde) and DMTA (5'-deoxy-5'(methyl-thio)-adenosine) were purchased from Sigma Company in the United States. ADDA was dissolved in deionized water to make a 10mM stock solution; DMTA was dissolved in DMSO (dimethyl sulfoxide) to make a 0.5M stock solution.

[0024] 2) Cell culture

[0025] Human erythroid K562 cells were cultured in RPMI1640 medium at 37°C, 10% calf serum, 10 5 U / L penicillin, 100mg / L streptomycin, 5% CO 2 . K562 cells were treated with a final concentration of 50μM ADDA or 0.1mM DMTA for 72 hours, and the cells were collected.

[0026] Human bone marrow CD34 + Cells were separated with CD34 immunomagnetic beads (Miltenyi Biotec, USA), 50μM ADDA or 100μM DMTA was added, normal saline or DMSO (volume ratio 2 . Specifically, the cytokine SCF (100ng / ml), IL-3 (10ng / ml) and Flt-3 (10ng / ml) were added to the culture medium for 1 week, and then replaced with only the cytokine EPO (5U / ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biological medicine, discloses an application of ADDA and / or DMTA in preparing medicine for improving expression level of gamma-globin, and provides a candidate drug for curing anemia caused by beta-thalassemia, sickle-cell anemia, hematopoietic system tumor and hematopoietic dysfunction.

Description

Technical field [0001] The present invention belongs to the technical field of biomedicine, and relates to ADDA (adenosine-2', 3'-dialdehyde, 2', 3'-dialdehyde adenosine) and / or DMTA (5'-deoxy-5'(methyl-thio)adenosine) , 5'-deoxy-5'-methylthioadenosine), especially related to the application of ADDA and / or DMTA in the preparation of drugs that increase the expression of γ-globin, and in the preparation and treatment of β-thalassemia And sickle cell anemia, hematopoietic system disorders or tumor-caused anemia drugs. Background technique [0002] Hemoglobin in adults consists of two α-globin subunits and two β-globin subunits (α2β2). The human β-like globin gene cluster is located on the short arm of chromosome 11 and contains five globin genes (ε, G γ, A γ, δ, β), encoding β-like globin to synthesize hemoglobin. In the process of human ontogeny, each globin gene is turned on and expressed strictly according to the specific development period and tissue specificity. From concep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7076A61P7/06
Inventor 赵权马驰何颖红
Owner NANJING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap